Investigating how a specific protein affects insulin release in diabetes

ArpC3-mediated actin remodeling in insulin granule exocytosis and diabetes

NIH-funded research Medical College of Wisconsin · NIH-11001943

This study is looking at how a protein called ArpC3 affects insulin release from the cells that produce it in people with type-2 diabetes, with the hope of finding new ways to help improve insulin function and treat the condition.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMedical College of Wisconsin NIH-funded
Lab location1 site (Milwaukee, United States)
Project IDNIH-11001943 on NIH RePORTER

What this research studies

This research focuses on understanding the role of ArpC3, a protein involved in the remodeling of actin filaments, in the process of insulin secretion from beta cells in individuals with type-2 diabetes. By examining how changes in the structure of actin influence insulin release, the study aims to uncover new therapeutic targets that could help restore normal insulin function. The approach includes advanced imaging techniques and functional assays to observe the behavior of beta cells and their signaling pathways. If successful, this research could lead to innovative treatments for diabetes by improving insulin secretion.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with type-2 diabetes who are over 21 years old.

Not a fit: Patients with type-1 diabetes or those under 21 years old may not receive benefit from this research.

Why it matters

Potential benefit: If successful, this research could provide new strategies to enhance insulin secretion in patients with type-2 diabetes.

How similar studies have performed: Previous research has shown promising results in understanding the role of actin remodeling in insulin secretion, indicating that this approach has potential for success.

Where this research is happening

Milwaukee, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions adult onset diabetesAdult-Onset Diabetes Mellitus
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.